Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study

Irıs D. Nagtegaal(Radboud University Nijmegen), J. Han van Krieken(Radboud University Nijmegen), A.A. Mulder-Stapel(Leiden University Medical Center), J. Hermans(Ludwig-Maximilians-Universität München), Cornelis JH van de Velde(Leiden University), Elma Meershoek‐Klein Kranenbarg(Leiden University Medical Center), Corrie A.M. Marijnen(Leiden University Medical Center)
BMC Cancer
July 16, 2001
10.1186/1471-2407-1-7
Cited by 142

Related Papers

Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936
|Leukemia|2003|3k
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
|Annals of Oncology|2012|1.5k
Gastric cancer
|The Lancet|2009|890
Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1
|Nature Genetics|2008|818
MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program
|Blood|2013|677